FOXA1 and Familial prostate cancer: Anchoring our analysis to the FOXA1 promoter and using accessible chromatin regions defined in LNCaP prostate cancer cells identified 55 putative CREs to the FOXA1 regulatory plexus (r > 0.7) (Fig. 2b).